Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Shares Issued (2020 - 2023)

Historic Shares Issued for Terns Pharmaceuticals (TERN) over the last 4 years, with Q4 2023 value amounting to $142000.0.

  • Terns Pharmaceuticals' Shares Issued fell 9982.49% to $142000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $81.3 million, marking a year-over-year increase of 19.97%. This contributed to the annual value of $1.4 million for FY2024, which is 25317.07% up from last year.
  • As of Q4 2023, Terns Pharmaceuticals' Shares Issued stood at $142000.0, which was down 9982.49% from $20000.0 recorded in Q3 2023.
  • Over the past 5 years, Terns Pharmaceuticals' Shares Issued peaked at $136.4 million during Q1 2021, and registered a low of $20000.0 during Q3 2023.
  • In the last 4 years, Terns Pharmaceuticals' Shares Issued had a median value of $115000.0 in 2020 and averaged $36.3 million.
  • Data for Terns Pharmaceuticals' Shares Issued shows a peak YoY increase of 9982.49% (in 2023) and a maximum YoY decrease of 9982.49% (in 2023) over the last 5 years.
  • Terns Pharmaceuticals' Shares Issued (Quarter) stood at $88000.0 in 2020, then skyrocketed by 154856.82% to $136.4 million in 2021, then crashed by 40.51% to $81.1 million in 2022, then tumbled by 99.82% to $142000.0 in 2023.
  • Its last three reported values are $142000.0 in Q4 2023, $20000.0 for Q3 2023, and $81.1 million during Q4 2022.